Markus Kaski

1.1k total citations
41 papers, 782 citations indexed

About

Markus Kaski is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience. According to data from OpenAlex, Markus Kaski has authored 41 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cognitive Neuroscience. Recurrent topics in Markus Kaski's work include Down syndrome and intellectual disability research (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (7 papers). Markus Kaski is often cited by papers focused on Down syndrome and intellectual disability research (8 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (7 papers). Markus Kaski collaborates with scholars based in Finland, Poland and United Kingdom. Markus Kaski's co-authors include Matti Iivanainen, Tuomo Määttä, Anja Taanila, Kristiina Patja, Reijo Sund, ­Eero Pukkala, Maija‐Liisa Laakso, Lea Leinonen, Jorma Kokkonen and Lauri J. Virta and has published in prestigious journals such as Neuroscience, International Journal of Cancer and SLEEP.

In The Last Decade

Markus Kaski

37 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Kaski Finland 15 290 195 174 133 111 41 782
Tiina K. Urv United States 17 414 1.4× 197 1.0× 181 1.0× 234 1.8× 76 0.7× 23 969
Györgyi Csábí Hungary 15 215 0.7× 152 0.8× 50 0.3× 133 1.0× 166 1.5× 35 752
David K. Urion United States 17 99 0.3× 203 1.0× 108 0.6× 114 0.9× 219 2.0× 41 755
Marie Bækvad‐Hansen Denmark 18 134 0.5× 153 0.8× 118 0.7× 319 2.4× 230 2.1× 43 1.1k
Anne Tournay United States 13 161 0.6× 560 2.9× 179 1.0× 187 1.4× 333 3.0× 20 1.1k
Hubertus von Voß Germany 17 454 1.6× 199 1.0× 113 0.6× 170 1.3× 558 5.0× 37 1.4k
Alberto Vélez-van-Meerbeke Colombia 16 75 0.3× 285 1.5× 172 1.0× 80 0.6× 231 2.1× 68 921
Antonia Coppus Netherlands 17 662 2.3× 209 1.1× 87 0.5× 183 1.4× 55 0.5× 35 1.1k
Hiroshi Yamashita Japan 19 253 0.9× 83 0.4× 60 0.3× 52 0.4× 250 2.3× 60 1.1k
Rosemarie Plaetke United States 18 95 0.3× 141 0.7× 94 0.5× 220 1.7× 52 0.5× 29 987

Countries citing papers authored by Markus Kaski

Since Specialization
Citations

This map shows the geographic impact of Markus Kaski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kaski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kaski more than expected).

Fields of papers citing papers by Markus Kaski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kaski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kaski. The network helps show where Markus Kaski may publish in the future.

Co-authorship network of co-authors of Markus Kaski

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Kaski. A scholar is included among the top collaborators of Markus Kaski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Kaski. Markus Kaski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaski, Markus, et al.. (2017). The nationwide register‐based prevalence of intellectual disability during childhood and adolescence. Journal of Intellectual Disability Research. 61(8). 802–809. 14 indexed citations
2.
Zagrodzki, Paweł, Joanna Chłopicka, H. Bartoń, et al.. (2011). Valproic Acid Modulates Superoxide Dismutase, Uric Acid-Independent FRAP and Zinc in Blood of Adult Epileptic Patients. Biological Trace Element Research. 143(3). 1424–1434. 14 indexed citations
3.
Ounjaijean, Sakaewan, T. Westermarck, Markku Partinen, et al.. (2011). Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. International Journal of Clinical Pharmacology and Therapeutics. 49(4). 268–276. 17 indexed citations
4.
Sivenius, Juhani, et al.. (2009). Therapeutic intervention in mentally retarded adult epileptics. Acta Neurologica Scandinavica. 81(2). 165–167.
5.
Åberg, L., et al.. (2008). Childhood growth and development associated with need for full-time special education at school age. European Journal of Paediatric Neurology. 13(1). 18–27. 4 indexed citations
6.
7.
Määttä, Tuomo, Markus Kaski, Anja Taanila, Sirkka Keinänen‐Kiukaanniemi, & Matti Iivanainen. (2006). Sensory impairments and health concerns related to the degree of intellectual disability in people with Down syndrome. Down Syndrome Research and Practice. 11(2). 78–83. 25 indexed citations
8.
Kaipainen, Pekka, T. Westermarck, Markus Kaski, M. Iivanainen, & Faik Atroshi. (2006). Determination of levetiracetam in patients with epilepsy and intellectual disability. Epilepsia. 47. 133–133. 1 indexed citations
9.
Määttä, Tuomo, et al.. (2006). Mental health, behaviour and intellectual abilities of people with Down syndrome. Down Syndrome Research and Practice. 11(1). 37–43. 103 indexed citations
10.
Laakso, Minna, et al.. (2005). Urinary 6‐hydroxymelatonin sulfate excretion in intellectually disabled subjects with sleep disorders and multiple medications: Validation of measurements in urine extracted from diapers. Scandinavian Journal of Clinical and Laboratory Investigation. 65(5). 413–432. 3 indexed citations
11.
Laakso, Maija‐Liisa, et al.. (2004). Wrist actigraphy in estimation of sleep and wake in intellectually disabled subjects with motor handicaps. Sleep Medicine. 5(6). 541–550. 22 indexed citations
12.
Heiskala, Hannu, et al.. (2002). Sleep fragmentation in mentally retarded people decreases with increasing daylength in spring. Chronobiology International. 19(2). 441–459. 9 indexed citations
13.
Heiskala, Hannu, et al.. (2001). Neurological impairments and sleep–wake behaviour among the mentally retarded. Journal of Sleep Research. 10(4). 309–318. 36 indexed citations
14.
15.
Nissinen, Markku, et al.. (2000). Smith-Lemli-Opitz syndrome and other sterol disorders among Finns with developmental disabilities. Journal of Laboratory and Clinical Medicine. 136(6). 457–467. 8 indexed citations
16.
Nokelainen, Pekka, Hannu Heiskala, Anna‐Elina Lehesjoki, & Markus Kaski. (2000). A Patient With 2 Different Repeat Expansion Mutations. Archives of Neurology. 57(8). 1199–1199. 5 indexed citations
17.
Kaski, Markus, et al.. (1999). Aetiology of intellectual disability – the Finnish classification: development of a method to incorporate WHO ICD‐10 coding. Journal of Intellectual Disability Research. 43(3). 242–250. 7 indexed citations
18.
Soininen, Hilkka, Juhani Partanen, E.-L. Helkala, et al.. (1993). Age-related cognitive decline and electroencephalogram slowing in down's syndrome as a model of Alzheimer's disease. Neuroscience. 53(1). 57–63. 29 indexed citations
19.
Heinonen, Outi, Hilkka Soininen, Markus Kaski, et al.. (1993). Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome. Neuroscience Letters. 149(1). 67–70. 9 indexed citations
20.
Kaski, Markus, et al.. (1991). Treatment of epilepsy in mentally retarded patients with a slow‐release carbamazine preparation. Journal of Intellectual Disability Research. 35(3). 231–239. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiina K. Urv Breakdown of academic impact, for papers by Györgyi Csábí Breakdown of academic impact, for papers by David K. Urion Breakdown of academic impact, for papers by Marie Bækvad‐Hansen Breakdown of academic impact, for papers by Anne Tournay Breakdown of academic impact, for papers by Hubertus von Voß Breakdown of academic impact, for papers by Alberto Vélez-van-Meerbeke Breakdown of academic impact, for papers by Antonia Coppus Breakdown of academic impact, for papers by Hiroshi Yamashita Breakdown of academic impact, for papers by Rosemarie Plaetke
Rankless by CCL
2026